Search

everythinglearnresearchcommunity

for

Search:↓

Growth factors are crucial for hair development and could help treat hair diseases.

Nearly half of the French individuals surveyed reported having a sensitive scalp, more common in women, often linked to hair loss and symptoms like itching, and triggered by factors including shampoos and pollution.

Vitiligo affects overall health and self-esteem, needing more research and awareness.

Toxic Shock Syndrome progresses quickly, often involves multiple organs, and is linked to Staphylococcus aureus toxins, with treatment options available but diagnostic challenges remaining.

Platelet-rich plasma may help in skin and hair treatments, and with muscle and joint healing, but more research is needed to fully understand its benefits and limitations.

Electrospun nanofibers show promise for enhancing blood vessel growth in tissue engineering but need further research to improve their effectiveness.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Coffee silverskin may be a beneficial and safe ingredient for cosmetics, offering hydration, firmness, and potential hair growth benefits.

Extracts from Tridax procumbens L. have strong anti-inflammatory and antioxidant effects and block inflammation-causing enzymes.

Cats with atopic dermatitis often have severe, year-round itching and respond well to certain treatments.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Both mouse and rat models are effective for testing alopecia areata treatments.

SHBG may be a useful early indicator and treatment target for PCOS.

Acne significantly affects mental health and quality of life, with research suggesting hormonal and genetic factors in its development and emphasizing early treatment to prevent scarring.

Cyclosporin A helps mice grow hair by blocking a specific protein activity in skin cells.

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Combining diphenylcyclopropenone with anthralin is more effective for hair regrowth in alopecia areata than using diphenylcyclopropenone alone, but may cause more side effects.

Engineered skin substitutes can grow hair but have limitations like missing sebaceous glands and hair not breaking through the skin naturally.

Hydrogen peroxide can cause scars by changing healing processes and increasing certain protein levels.

Hormones during pregnancy and lactation keep skin stem cells inactive, preventing hair growth.

Androgens may block hair growth signals, targeting this could treat hair loss.

Different lab conditions and light treatment methods change how human skin cells respond to light therapy.